U.S. market Closed. Opens in 11 hours 24 minutes

BNTX | BioNTech SE Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue3.82B17.31B18.98B482.32M108.59M127.58M61.60M
Cost of Revenue599.80M4.53B3.86B704.36M243.83M156.73M94.81M
Gross Profit3.22B12.78B15.12B-222.04M-135.24M-29.16M-33.22M
Operating Expenses2.31B135.90M200.10M-139.62M46.28M24.70M114.99M
Selling, General & Admin557.70M544.20M328.90M108.56M43.41M27.09M29.49M
Research & Development1.78B116.00M102.70M645.03M226.47M143.04M85.50M
Other Operating ExpensesN/A-524.30M-128.80M-893.21M-223.60MN/AN/A
Operating Income690.40M12.64B15.28B-82.42M-181.52M-53.85M-61.28M
Other Expenses / Income-67.80M311.40M-237.40M-63.38M2.08M5.97M-26.03M
Before Tax Income1.19B12.95B15.05B-145.80M-179.44M-47.66M-85.91M
Income Tax Expenses255.80M3.52B4.75B-161.00M-268.00K600.00K45.00K
Net Income930.30M9.43B10.29B15.20M-179.17M-48.02M-85.65M
Interest Expenses7.74M18.90M5.40M64.95M1.72M1.72M676.00K
Basic Shares Outstanding240.60M243.30M244.00M235.44M211.50M226.86M226.86M
Diluted Shares Outstanding242.70M249.80M259.70M248.53M211.50M226.86M226.86M
EBITDA1.16B13.10B14.97B-42.11M-146.17M-30.01M-74.40M
EBITDA Margin30.25%75.65%78.89%-8.73%-134.61%-23.52%-120.79%
EBIT1.19B12.97B15.05B-80.85M-177.72M-45.70M-84.93M
EBIT Margin31.26%74.94%79.32%-16.76%-163.66%-35.82%-137.88%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙